Anti-TYW1B monoclonal antibody

Pre-made anti-TYW1B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TYW1B/TYW1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2920-Ab-1/ GM-Tg-hg-IP2920-Ab-2Anti-Human TYW1B monoclonal antibodyHuman
GM-Tg-rg-IP2920-Ab-1/ GM-Tg-rg-IP2920-Ab-2Anti-Rat TYW1B monoclonal antibodyRat
GM-Tg-mg-IP2920-Ab-1/ GM-Tg-mg-IP2920-Ab-2Anti-Mouse TYW1B monoclonal antibodyMouse
GM-Tg-cynog-IP2920-Ab-1/ GM-Tg-cynog-IP2920-Ab-2Anti-Cynomolgus/ Rhesus macaque TYW1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2920-Ab-1/ GM-Tg-felg-IP2920-Ab-2Anti-Feline TYW1B monoclonal antibodyFeline
GM-Tg-cang-IP2920-Ab-1/ GM-Tg-cang-IP2920-Ab-2Anti-Canine TYW1B monoclonal antibodyCanine
GM-Tg-bovg-IP2920-Ab-1/ GM-Tg-bovg-IP2920-Ab-2Anti-Bovine TYW1B monoclonal antibodyBovine
GM-Tg-equg-IP2920-Ab-1/ GM-Tg-equg-IP2920-Ab-2Anti-Equine TYW1B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2920-Ab-1/ GM-Tg-hg-IP2920-Ab-2; GM-Tg-rg-IP2920-Ab-1/ GM-Tg-rg-IP2920-Ab-2;
GM-Tg-mg-IP2920-Ab-1/ GM-Tg-mg-IP2920-Ab-2; GM-Tg-cynog-IP2920-Ab-1/ GM-Tg-cynog-IP2920-Ab-2;
GM-Tg-felg-IP2920-Ab-1/ GM-Tg-felg-IP2920-Ab-2; GM-Tg-cang-IP2920-Ab-1/ GM-Tg-cang-IP2920-Ab-2;
GM-Tg-bovg-IP2920-Ab-1/ GM-Tg-bovg-IP2920-Ab-2; GM-Tg-equg-IP2920-Ab-1/ GM-Tg-equg-IP2920-Ab-2
Products NameAnti-TYW1B monoclonal antibody
Formatmab
Target NameTYW1B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TYW1B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2920-Ag-1Recombinant multi-species TYW1B/ LINC00069/ NCRNA00069 protein


    Target information

    Target IDGM-IP2920
    Target NameTYW1B
    Gene ID441250
    Gene Symbol and SynonymsLINC00069,NCRNA00069,RSAFD2,TYW1B
    Uniprot AccessionQ6NUM6
    Uniprot Entry NameTYW1B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000277149
    Target ClassificationN/A

    The target: TYW1B, gene name: TYW1B, also named as LINC00069, NCRNA00069, RSAFD2. Wybutosine is a hypermodified guanosine found in phenylalanine tRNA. Wybutosine functions to stabilize codon-anticodon interactions during ribosome decoding and therefore supports the maintenance of the reading frame. In yeast, the homolog of this gene is essential for the synthesis of wybutosine. The human genome contains two closely related genes that putatively function in wybutosine synthesis. The open reading frame of this locus is disrupted in some individuals. Thus, this locus appears to be an evolving pseudogene, but may still be functional in some members of the population. [provided by RefSeq, Apr 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.